THPTA ligand
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
F4050 | 100 mg | $65 | in stock | |
H4050 | 500 mg | $199 | 5 days | |
I4050 | 1 g | $369 | in stock | |
K4050 | 5 g | $1568 | in stock |
THPTA ligand (tris-hydroxypropyltriazolylmethylamine) is a triazole ligand for water-based copper-catalyzed click chemistry reactions. This reagent is very well water-soluble. It is especially useful for click chemistry labeling and conjugation of proteins, including antibodies, when organic co-solvents are undesirable.
Customers also purchased with this product
BDP TR azide
BDP TR is a red-emitting fluorophore for the ROX channel. This is an azide for copper-catalyzed and copper-free сlick chemistry conjugation.Biotin phosphoramidite (hydroxyprolinol)
Biotin phosphoramidite reagent for the synthesis of biotinylated oligos. Contains a dimethyoxytrityl group.
Add this product to your cart and
get free express delivery
get free express delivery
5-Ethynyl-uridine (EU)
Uridine alkyne derivative for monitoring and investigation of RNA transcription in cells.General properties
Appearance: | off white solid |
Molecular weight: | 434.5 |
CAS number: | 760952-88-3 |
Molecular formula: | C18H30N10O3 |
IUPAC name: | 3-[4-[[bis[[1-(3-hydroxypropyl)triazol-4-yl]methyl]amino]methyl]triazol-1-yl]propan-1-ol |
Solubility: | good in water, DMF, DMSO |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. |
MSDS: | Download |
Product specifications |
Product citations
- Cardenas, A.J.; Thomas, K.S.; Broden, M.W.; Ferraro, N.J.; John, C.M.; Pires, M.M.; Jarvis, G.A.; Criss, A.K. Neisseria gonorrhoeaescavenges host sialic acid for Siglec-mediated, complement-independent suppression of neutrophil activation. bioRxiv, 2024, preprint. doi: 10.1101/2024.01.17.576097
- Slapak, E.J.; el Mandili, M.; Ten Brink, M.S.; Kros, A.; Bijlsma, M.F.; Spek, C.A. CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer. Cancer Letters, 2024, 590, 216845. doi: 10.1016/j.canlet.2024.216845
- Narum, S.; Deal, B.; Ogasawara, H.; Mancuso, J. N.; Zhang, J.; Salaita, K. An Endosomal Escape Trojan Horse Platform to Improve Cytosolic Delivery of Nucleic Acids. ACS Nano, 2024, 18(8), 6186–6201. doi: 10.1021/acsnano.3c09027
- Slapak, E.J.; el Mandili, M.; Brink, M.S.T.; Kros, A.; Bijlsma, M.F.; Spek, C.A. Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer. International Journal of Molecular Sciences, 2023, 24(13), 10704. doi: 10.3390/ijms241310704
Your item has been added.
View your
cart
or
proceed to checkout
The count of items is incorrect.